Labcorp Holdings Inc. upgraded to Buy: resilient diagnostics demand, strong Q2, modest valuation and new tests offset ...

LH shares are currently down 8.9% from their 52-week high of $341.80, achieved on Aug. 27. Over the past three months, LH ...

Stricter safety rules, drug innovation and CRO outsourcing drive demand, while imaging, CRISPR and data analytics improve testing and reduce animal use.Dublin, Sept. (GLOBE NEWSWIRE) -- "In Vivo ...

According to MarketsandMarkets™, the Healthcare Analytical Testing Services Market is projected to reach USD 12,470 million by 2031 from ...

Usually not, with one large exception. Standard drug panels don't test for muscimol, the active compound in the Amanita ...

The global pharmacogenomics market was valued at USD 5.7 billion in 2025 and is projected to reach USD 15.4 billion by 2035, growing at a CAGR of 10.6%. The global pharmacogenomics market is gaining m ...

In Q2 2026, the Harbor SMID Cap Value ETF (NAV) returned 22.76%, outperforming its benchmark, the Russell 2500 Value Index, ...

Clinical Trial Investigative Site Network Market growth is driven by rising drug development activity, decentralized trials, ...

Shares of diagnostic-testing companies declined after the Centers for Medicare & Medicaid Services proposed cuts to Medicare payment rates for laboratory services. Labcorp Holdings stock slid 5.9% to ...

Quest Diagnostics Incorporated is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows: - ...

Million Awarded to DFC Community Coalitions to Strengthen Primary Prevention WASHINGTON, D.C. — Today, the White House Office of National Drug ...